Publications by authors named "Peter J Devries"

Claim this Profile
C
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate.
Andrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, Hugh D Falls, Michael J Mitten, Peter J DeVries

Mol Cancer Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope.
Andrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, Michael J Mitten, Suzanne Norvell, Peter J DeVries

Mol Cancer Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody.
Edward B Reilly, Andrew C Phillips, Fritz G Buchanan, Gillian Kingsbury, Yumin Zhang, Peter J DeVries

Mol Cancer Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potency of erythropoietin-mimic antibodies correlates inversely with affinity.
Susan E Lacy, Peter J DeVries, Nancy Xie, Emma Fung, Richard R Lesniewski

J Immunol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potent erythropoietin-mimicking human antibody interacts through a novel binding site.
Zhihong Liu, Vincent S Stoll, Peter J Devries, Clarissa G Jakob, Nancy Xie

Blood· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis